Skip Navigation

Cardiovascular Research 2003 59(2):369-379; doi:10.1016/S0008-6363(03)00432-2
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kirchhefer, U.
Right arrow Articles by Jones, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchhefer, U.
Right arrow Articles by Jones, L. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Impaired relaxation in transgenic mice overexpressing junctin

Uwe Kirchhefera,*, Joachim Neumanna, Donald M. Bersb, Igor B. Buchwalowc, Larissa Fabritzd, Gabriela Hanskea, Isabel Justusa, Burkhard Riemanne, Wilhelm Schmitza and Larry R. Jonesf

aInstitut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität, Domagkstraße 12, 48149 Münster, Germany
bDepartment of Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
cMedizinische Klinik B und Zentrale Projektgruppe Ultrastrukturforschung am Gerhard-Domagk-Institut für Pathologie, Westfälische Wilhelms-Universität, 48149 Münster, Germany
dMedizinische Klinik und Poliklinik C, Westfälische Wilhelms-Universität, 48149 Münster, Germany
eKlinik und Poliklinik für Nuklearmedizin, Westfälische Wilhelms-Universität, 48149 Münster, Germany
fDepartment of Medicine, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA

* Corresponding author. Tel.: +49-251-835-5510; fax: +49-251-835-5501. kirchhef{at}uni-muenster.de

Objective: Junctin is a major transmembrane protein in cardiac junctional sarcoplasmic reticulum, which forms a quaternary complex with the ryanodine receptor (Ca2+ release channel), triadin, and calsequestrin. Methods: To better understand the role of junctin in excitation–contraction coupling in the heart, we generated transgenic mice with targeted overexpression of junctin to mouse heart, using the {alpha}-MHC promoter to drive protein expression. Results: The protein was overexpressed 10-fold in mouse ventricles and overexpression was accompanied by cardiac hypertrophy (19%). The levels of two other junctional SR-proteins, the ryanodine receptor and triadin, were reduced by 32% and 23%, respectively. However, [3H]ryanodine binding and the expression levels of calsequestrin, phospholamban and SERCA2a remained unchanged. Cardiomyocytes from junctin-overexpressing mice exhibited impaired relaxation: Ca2+ transients decayed at a slower rate and cell relengthening was prolonged. Isolated electrically stimulated papillary muscles from junctin-overexpressing hearts exhibited prolonged mechanical relaxation, and echocardiographic parameters of relaxation were prolonged in the living transgenic mice. The amplitude of caffeine-induced Ca2+ transients was lower in cardiomyocytes from junctin-overexpressing mice. The inactivation kinetics of L-type Ca2+ channel were prolonged in junctin-overexpressing cardiomyocytes using Ca2+ or Ba2+ as charge carriers. Conclusion: Our data provide evidence that cardiac-specific overexpression of junctin is accompanied by impaired myocardial relaxation with prolonged Ca2+ transient kinetics on the cardiomyocyte level.

KEYWORDS bp, base pairs; EGTA, ethylene glycol bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid; HEPES, (N-[2-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]); PAGE, polyacrylamide gel electrophoresis; SDS, sodium n-dodecyl sulphate; SR, sarcoplasmic reticulum


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
P. D. Allen
Triadin, not essential, but useful
J. Physiol., July 1, 2009; 587(13): 3123 - 3124.
[Full Text] [PDF]


Home page
J. Physiol.Home page
T. J. Pritchard and E. G. Kranias
Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis
J. Physiol., July 1, 2009; 587(13): 3125 - 3133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-B. Shen, R. Shutt, M. Agosto, A. Pappano, and B. T. Liang
Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1089 - H1095.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Grote-Wessels, H. A. Baba, P. Boknik, A. El-Armouche, L. Fabritz, H.-J. Gillmann, D. Kucerova, M. Matus, F. U. Muller, J. Neumann, et al.
Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload
Cardiovasc Res, August 1, 2008; 79(3): 464 - 471.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.